CorrespondenceMetastatic basal cell carcinoma with neuroendocrine differentiation: complete response to cemiplimab.
Clin Exp Dermatol
; 49(9): 1060-1062, 2024 Aug 22.
Article
in En
| MEDLINE
| ID: mdl-38494790
Full text:
1
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Carcinoma, Basal Cell
/
Antibodies, Monoclonal, Humanized
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Year:
2024
Type:
Article